AGI Dermatics is a bio-pharmaceutical company that develops and sells high-end skincare products and cosmetic ingredients. The Company's core products are based on DNA repair enzymes that are intended to complement skin cells' natural DNA repair capacity. AGI Dermatics was acquired by the Estee Lauder Companies (NYSE: EL) in September 2008.
The information provided herein should not be considered a recommendation to purchase or sell any particular investment. There is no assurance that any investment discussed herein will remain in the relevant fund at the time you review this website. The investments discussed do not represent the relevant fund's entire holdings. It should not be assumed that any of the investments discussed was or will prove to be profitable, or that the investment recommendations or decisions SMC makes in the future will be profitable or equal the performance of the investments discussed herein.